Photodynamic therapy, both eyes, including the infusion of Verteporfin continuously through a peripheral vein, using a non-thermal laser at a wavelength of 689nm, for the treatment of choroidal neovascularisation.
Photodynamic therapy, both eyes, including the infusion of Verteporfin continuously through a peripheral vein, using a non-thermal laser at a wavelength of 689nm, for the treatment of choroidal neovascularisation.
| Release | Change | Old | New |
|---|---|---|---|
| July 2026 | Fee ↑ | $637.15 | $653.7 |
Data sourced from Australian Government publications · Not an official government service